Market Assessment Underway by PTSC to Complement Strong Product Review

CARLSBAD, Calif., Oct. 29 /PRNewswire-FirstCall/ -- Patriot Scientific Corporation (OTC Bulletin Board: PTSC - News) announced that Eclat Consulting, LLC, ("Eclat") will launch a market validation study of the Company's flagship technology, the Crossflo DataExchange platform ("CDX"). This follows on the heels of a completed independent assessment conducted by a Fortune 1000 technology firm in which CDX scored very high marks in all significant categories including product stability, code quality, and overall design rigor.

The Eclat team, lead by CEO Greg Baroni, recently assisted the Company with an assessment of key management, and has also been working with the Company to identify strategic options for the Company's wholly owned subsidiary, Patriot Data Solutions Group ("PDSG"). Patriot's Board engaged Eclat's team of experienced business consultants to help assess the strategic direction of PDSG and to assist in identifying the optimum operational structure and focus of PDSG.

In addition, Eclat is assisting the Company in its search for a Chief Executive Officer with targeted industry experience able to take the company to the next level of growth and revenue. The market validation study will be an essential tool in framing the competencies sought for the CEO candidate.

About Eclat Consulting, LLC ("Eclat")

Eclat - literally, "brilliance of success." And, put simply, our success is defined by the brilliance of our clients' success. We are a different kind of professional services company - problem solvers who deliver tangible performance improvements. Eclat delivers a comprehensive range of services, including strategic, operational support, healthcare, security, and application services. Proven performance and forward thinking - it's Eclat's foundation. For more information on how Eclat is different, visit: www.eclatllc.com.

About Patriot Scientific

Headquartered in Carlsbad, California, Patriot Scientific Corporation provides data sharing and secure data solutions for a connected world. Patriot Scientific addresses the expanding market opportunities in the healthcare, justice and public safety industries through its wholly owned subsidiary Patriot Data Solutions Group, Inc. These growth activities are funded with revenues generated, in a large part, from the continuing successful Moore Microprocessor Patent(TM) Portfolio licensing partnership with The TPL Group. Patriot Scientific's integrated core intelligence solution addresses the critical data/information sharing needs of the healthcare industry, the Department of Homeland Security, the Department of Justice, and federal, state, and local public safety and law enforcement agencies. For more information on Patriot Scientific Corporation, visit: www.ptsc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this news release looking forward in time involve risks and uncertainties, including the risks associated with the effect of changing economic conditions, trends in the products markets, variations in the company's cash flow, market acceptance risks, patent litigation, technical development risks, seasonality and other risk factors detailed in the company's Securities and Exchange Commission filings.